Comparing AppYea (OTCMKTS:APYP) and Semantix (NASDAQ:STIX)

Institutional & Insider Ownership

40.1% of Semantix shares are owned by institutional investors. 0.5% of AppYea shares are owned by company insiders. Comparatively, 35.5% of Semantix shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Volatility and Risk

AppYea has a beta of 2.27, indicating that its share price is 127% more volatile than the S&P 500. Comparatively, Semantix has a beta of -0.37, indicating that its share price is 137% less volatile than the S&P 500.

Profitability

This table compares AppYea and Semantix’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
AppYea	N/A	N/A	-269.35%
Semantix	-69.49%	-45.45%	-26.98%

Earnings & Valuation

This table compares AppYea and Semantix”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AppYea	N/A	N/A	-$1.82 million	($0.01)	-1.20
Semantix	$264.23 million	0.00	-$63.61 million	($0.81)	N/A

AppYea has higher earnings, but lower revenue than Semantix. AppYea is trading at a lower price-to-earnings ratio than Semantix, indicating that it is currently the more affordable of the two stocks.

About AppYea

AppYea, Inc., a digital health company, develops wearable monitoring solutions to treat sleep apnea and snoring. It develops AppySleep app, a wristband that monitors physiological parameters during sleep; AppySleep, a biofeedback snoring treatment wristband; AppySleep LAB, a smartphone medical application that monitors breathing patterns in the sleep and identify sleep arena episode without direct contact to the user; and AppySleep PRO a wristband for the treatment of sleep arena using biofeedback in combination with AppySleep LAB app. The company was founded in 2012 and is based in Gan Yavne, Israel.

About Semantix

Semantix, Inc., together with its subsidiaries, provides end-to-end proprietary Software as a Service (SaaS) data platform in Latin America and the United States. The company offers SDP, a multi-cloud SaaS data platform that provides data integration, data operations, machine learning operations, data governance, data sharing, and data visualization for financial institutions; healthcare plans operators, health insurance brokers, hospitals, clinics, and imaging and diagnostics facilities; and retailers. It also sells third-party software licenses to the finance, retail, telecommunications, healthcare, industrials, and other sectors. In addition, the company offers artificial intelligence and data analytics services, including consulting, cloud monitoring, data integration, data science, and data engineering. The company was founded in 2010 and is based in São Paulo, Brazil.